Pathfinder GAAP EPS of $0.42, revenue of $11.7M
财报/业绩新闻:Pathfinder GAAP EPS of $0.42, revenue of $11.7M 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
Market news
自动聚合美股、财报、宏观和热门标的新闻,固化为本站本地摘要页,并提取相关 ticker、中文摘要和期权研究提示。
Latest feed
当前只显示财报分类的本地新闻摘要,分页和跳转会保留这个分类。
财报/业绩新闻:Pathfinder GAAP EPS of $0.42, revenue of $11.7M 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:Investors are reacting negatively to weak guidance brought on by supply-chain pressures. 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:LIXIL Corporation GAAP EPS of -¥12.20, revenue of ¥379B 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:Combined profits of ExxonMobil and Chevron for the second quarter soared more than 300% in three months to more than $26 billion. 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:Higher prices lift global smartphone revenue 7% in Q2, Apple leads 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:Brookfield Business Corporation GAAP EPS of $0.18, revenue of $6.49M 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:IES Holdings Non-GAAP EPS of $6.70, revenue of $1.24B beats by $160M 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:AbbVie Non-GAAP EPS of $3.65 beats by $0.04, revenue of $16.99B beats by $230M 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:Earnings Snapshot: Dominion Energy reaffirms FY26 outlook as contracted data center capacity jumps 11% to ~53.8 GW 相关标的:USO, XLE。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:AXT jumps on strong Q2 results, as Wedbush sees continued optical strength 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:“Delaying Social Security until 70 results in an increased monthly payment — and that comes with proportionally higher cost-of-living adjustments.” 相关标的:COST。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。
财报/业绩新闻:Castle Biosciences raises 2026 revenue guidance to $365M-$375M as TissueCypher volume trends toward 50%-52% growth 暂未识别到明确 ticker,适合作为宏观或行业背景观察。
财报类新闻优先检查近月 IV、expected move、财报后波动压缩和价差流动性。